Advanced search
Publication Cover
Leukemia & Lymphoma Volume 43, 2002 - Issue 2
Submit an article Journal homepage
30
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Acute Myeloblastic Leukemia Achieving Complete Remission with Amifostine Alone

Ahmet Ozturk Department of Medical Oncology, Gülhane Military Medical Academy, Haydarpasa Teaching Hospital, Istanbul, Turkey
,
Bulent Orhan Department of Medical Oncology, Gülhane Military Medical Academy, Haydarpasa Teaching Hospital, Istanbul, Turkey
,
Orhan Turken Department of Medical Oncology, Gülhane Military Medical Academy, Haydarpasa Teaching Hospital, Istanbul, Turkey
,
Durmus Etiz Department of Radiation Oncology, Osmangazi University, Eskisehir, Turkey
,
Mustafa Yaylaci Department of Medical Oncology, Gülhane Military Medical Academy, Haydarpasa Teaching Hospital, Istanbul, Turkey
&
Necdet Uskent Department of Internal Medicine, Kadir Has University, Istanbul, Turkey
Pages 451-453 | Published online: 01 Jul 2009

  • Capizzi, R. (1999) "The preclinical basis for broad-spectrum selective cytoprotection of normal tissues from cytotoxic therapies by amifostine", Seminars in Oncology 26(Suppl. 7), 3-21.
  • Capizzi, R. (1999) "Recent developments and emerging options: the role of amifostine as a broad-spectrum cytoprotective agent", Seminars in Oncology 26(Suppl. 7), 1-2.
  • Eisenhauer, E.A. (1998) "Cytoprotection", Proceedings of the 23rd ESMO Congress (Education Book), pp. 109-114.
  • List, A.F, Heaton, R., Glinsmann-Gibson, B., et al. (1996) "Amifostine protects primitive hematopoietic progenitors against chemotherapy toxicity", Seminars in Oncology 23, 58-63.
  • Raza, A., Quawi, H., Lisak, L., et al. (2000) "Patients with myelodysplastic syndromes benefit from palliative therapy with amifostine, pentoxifylline, and ciprofloxacin with or without dexamethasone", Blood 95, 1580-1587.
  • Peddie, C.M, Wolf, C.R, McLellan, L.I, Collins, A.R. and Bowen, D.T. (1997) "Oxidative DNA damage in CD34+ myelodysplastic cells is associated with intracellular redox changes and elevated plasma tumor necrosis factor-a concentration", British Journal of Haematology 99, 625-631.
  • List, A.F, Brasfield, F., Heaton, R., et al. (1997) "Stimulation of hematopoiesis by amifostine in patients with myelodysplastic syndrome", Blood 90, 3364-3369.
  • Bowen, D.T, Denzlinger, C., Brugger, W., et al. (1998) "Poor response rate to a continuous schedule of amifostine therapy for low/intermediate risk myelodysplastic patients", British Journal of Haematology 103, 785-787.
  • List, A.F, Heaton, R., Glinsmann-Gibson, B., et al. (1998) "Amifostine stimulates formation of multipotent and erythroid bone marrow progenitors", Leukemia 12, 1596-1602.
  • Huang, X.K, Gao, X.Z, Burke, P., et al. (1997) "The effects of amifostine on the clonogenic proliferation in vitro of myelodysplastic and acute and chronic myelogenous leukemia cells (abstract)", Proceedings of American Society of Clinical Oncolology 16, 1848.
  • El-Ghissassi, F., Verhaehg, G. and Hainaut, P. (1997) "Modulation of wild-type p53 protein activity by the aminothiol amifostine", Proceedings of American Society of Clinical Oncology 16, 1958.
  • List, A.F. (1999) "Use of amifostine in hematologic malignancies myelodysplastic syndrome and acute leukemia", Seminars in Oncology 26(Suppl. 7), 61-65.
  • Santini, V. and Giles, F.J. (1999) "The potential of amifostine: from cytoprotectant to cytoprotective agent", Haematologica 84, 1035-1042.
  • Valeriote, F. and Tolen, S. (1982) "Protection and potentiation of nitrogen mustard cytotoxicity by WR-2721", Cancer Research 42, 4330-4331.
  • Poloni, A., Leoni, P., Curzi, L., et al. (1999) "Ex vivo pharmacological purging of leukopheresis collection with nitrogen mustard: amifostine pretreatment improves both early and late peripheral blood progenitor cell recovery", Experimental Hematology 27, 1548-1556.
  • Preisler, H., Venugopal, P., Galvez, A., et al. (1997) "Effective treatment of poor prognosis AML", Blood 80(Suppl), 2257a.
  • Scheinberg, D.A, Maslak, P. and Weiss, M. (1997) "Acute leukemias", In: DeVita, V.T, Hellman, S. and Rosenberg, S.A, eds, Cancer Principles and Practice of Oncology, 5th ed. (Lippincott-Raven, Philadelphia), pp 2293-2320.
  • Burnett, A.K. (1999) "Tailoring the treatment for acute myeloid leukemia", Current Opinions in Oncology 1, 14-19.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.